Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts ; volume:19 ; number:1 ; day:4 ; month:5 ; year:2021 ; pages:1-10 ; date:12.2021
Journal of translational medicine ; 19, Heft 1 (4.5.2021), 1-10, 12.2021
- Urheber
-
Moon, Jeonghyeon
Lee, Seon-yeong
Choi, Jeong Won
Lee, A Ram
Yoo, Jin Hee
Moon, Su-Jin
Park, Sung-Hwan
Cho, Mi-La
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-021-02860-z
- URN
-
urn:nbn:de:101:1-2021102818501906258091
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moon, Jeonghyeon
- Lee, Seon-yeong
- Choi, Jeong Won
- Lee, A Ram
- Yoo, Jin Hee
- Moon, Su-Jin
- Park, Sung-Hwan
- Cho, Mi-La
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux
Ssu72 attenuates autoimmune arthritis via targeting of STAT3 signaling and Th17 activation
Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma
GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation
Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
Phototherapy in Scleroderma
ROCK2, but not ROCK1 interacts with phosphorylated STAT3 and co-occupies TH17/TFH gene promoters in TH17-activated human T cells
STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux
Ssu72 attenuates autoimmune arthritis via targeting of STAT3 signaling and Th17 activation
Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma
GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation
Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
Phototherapy in Scleroderma
ROCK2, but not ROCK1 interacts with phosphorylated STAT3 and co-occupies TH17/TFH gene promoters in TH17-activated human T cells
STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux
Ssu72 attenuates autoimmune arthritis via targeting of STAT3 signaling and Th17 activation
Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma
GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation
Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
Phototherapy in Scleroderma
ROCK2, but not ROCK1 interacts with phosphorylated STAT3 and co-occupies TH17/TFH gene promoters in TH17-activated human T cells
STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation